期刊文献+

中药逆转肝癌多药耐药的研究现状(英文) 被引量:3

The status of Chinese medicine in reversing multi-drug resistance of hepatocellular carcinoma
下载PDF
导出
摘要 Multi-drug resistance(MDR) is a major obstacle in the chemotherapy of hepatocellular carcinoma.Comparing with western reversal agents,traditional Chinese medicine have advantages of low cost,hypotoxicity,wide safety range,broad-spectrum and multi-targets,etc.Therefore,traditional Chinese medicine may be expected to open up a new path to reverse MDR of liver cancer.Studies about applying traditional Chinese medicine to reverse MDR in hepatocellular carcinoma are outlined below. Multi-drug resistance(MDR) is a major obstacle in the chemotherapy of hepatocellular carcinoma.Comparing with western reversal agents,traditional Chinese medicine have advantages of low cost,hypotoxicity,wide safety range,broad-spectrum and multi-targets,etc.Therefore,traditional Chinese medicine may be expected to open up a new path to reverse MDR of liver cancer.Studies about applying traditional Chinese medicine to reverse MDR in hepatocellular carcinoma are outlined below.
机构地区 General Surgery
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2011年第9期541-546,共6页 中德临床肿瘤学杂志(英文版)
关键词 中医中药 肝癌 逆转 状态 抗性 传统中药 MDR 多药耐药 Chinese medicine multi-drug resistance reversing hepatocellular carcinoma
  • 相关文献

参考文献24

二级参考文献208

共引文献218

同被引文献107

引证文献3

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部